NCT03571633 Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03570697 Imaging of Coronary Plaques in Participants Treated With Evolocumab Status COMPLETED Phase PHASE3
NCT03554044 T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer Status COMPLETED Phase PHASE1
NCT03541369 Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia Status TERMINATED Phase PHASE1
NCT03539419 Study to Evaluate the Benefits for the Patient Associated With the Treatment of Plaque Psoriasis With Apremilast After Other Systemic Treatment in Conditions of Clinical Practice in Spain Status COMPLETED Phase N/A
NCT03532087 Study to Identify the Impact of Denosumab on the Immune System in Patients With HER2 Negative Breast Cancer Status WITHDRAWN Phase PHASE2
NCT03520231 Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases Status COMPLETED Phase PHASE2
NCT03512353 A Study of Carfilzomib Plus Dexamethasone in Adults With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers Status TERMINATED Phase PHASE2
NCT03500445 Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03476239 Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) Status COMPLETED Phase PHASE3
NCT03469661 Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS) Status COMPLETED Phase N/A
NCT03465540 Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies Status TERMINATED Phase PHASE1
NCT03461211 Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study Status COMPLETED Phase PHASE3
NCT03456856 A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction. Status COMPLETED Phase PHASE4
NCT03451422 Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1
NCT03448731 Skin Toxicity in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR and Chemotherapy (DERMIA) Status COMPLETED Phase PHASE2